Skip to main content
Explore URMC

Colon Cancer: Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

Research Question:
What are the good and bad effects of using the drug atezolizumab along with the usual chemotherapy, FOLFOX, compared to the usual chemotherapy, FOLFOX, alone?

Basic Study Information

This study has 2 groups. Group 1 will receive the usual chemotherapy treatment of FOLFOX plus the drug atezolizumab for 6 months, then patients will take atezolizumab alone for an additional 6 months. Group 2 will receive the usual chemotherapy which is FOLFOX for 6 months.

Location: Cancer Center
Study Web URL:
Study Reference #: CGIC17112

Lead Researcher (Principal Investigator)

Lead Researcher: Mohamedtaki Tejani, MD

Study Contact Information

Study Coordinator: Tanya Smith
Phone: (585) 275-8213

Additional Study Details

Learn More About These Conditions

More information about Colon Cancer

Return to Search